NCT00003348View on ClinicalTrials.gov

Carmustine Plus O(6)-Benzylguanine in Treating Patients With Recurrent or Progressive Gliomas of the Brain

PHASE1CompletedINTERVENTIONAL

Enrollment

56

Participants

Timeline

Start Date

May 31, 1998

Primary Completion Date

August 31, 2000

Study Completion Date

August 31, 2000

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG

O6-benzylguanine

DRUG

carmustine

Trial Locations (1)

27710

Duke Comprehensive Cancer Center, Durham

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Duke University

OTHER